medigraphic.com

2008, Number 1

<< Back Next >>

Rev Med Inst Mex Seguro Soc 2008; 46 (1)

Hospital Expenditures for Five Diseases of High Economic Impact

Zambrana M, Zurita B, Ramírez TJ, Coria I

Language: Spanish
References: 24
Page: 43-50
PDF size: 145.80 Kb.


ABSTRACT

Objective: to identify by gender and age group, the hospital expenditures of the diseases that have the major economic impact at Instituto Mexicano del Seguro Social through using the diagnosis related groups (DRG) classification system and by estimating their associated costs.
Methods: DRG system served to estimate hospital expenditures for five diseases: hypertension, type 2 diabetes, chronic renal failure, cervical cancer and HIV/AIDS. DRG allow for better estimation given that consider cost adjustment based on the amount of resources employed in the treatment of different episodes.
Results: in the year 2002, 6.7% of the hospital budget was assigned to the care of these five diseases. 42.6% of the expenditures were allocated to patients aged 60 years and older and 22.3% to patients from 50 to 59 years of age. Regarding diabetes mellitus and hypertension, care to patients over the age of 60 reached values of 55% and 57% of hospital expenditures respectively. Chronic renal failure and cervical cancer reached 60.5% and 72.8% of the expenditures, which were concentrated in patients aged 59 years or less; HIV/AIDS expenditures were distributed among patients from 20 to 50 years of age, the highest percentage (41.7%) was in the group of 30 to 39 years of age
Conclusions: is relevant to develop classification and information tools that consider the type of patients receiving hospital care, that are able to monitoring changes due to the demographic and epidemiologic transition processes, and that allow for sensitive outcomes measurement. These tools will help in achieving an adequate financing and planning of health expenditures.


REFERENCES

  1. Instituto Mexicano del Seguro Social. Informe al Ejecutivo Federal y al Congreso de la Unión sobre la Situación Financiera y los Riesgos del Instituto Mexicano del Seguro Social. Distrito Federal, México: Instituto Mexicano del Seguro Social; 2003. Disponible en http://www.imss.gob.mx/nr/imss/informes/ejecutivo/CAPITULO1.pdf

  2. Instituto Mexicano del Seguro Social. Informe al Ejecutivo Federal y al Congreso de la Unión sobre la Situación Financiera y los Riesgos del Instituto Mexicano del Seguro Social. Distrito Federal, México: Instituto Mexicano del Seguro Social; 2004.

  3. Secretaría de Salud. La salud de la población de edad avanzada. Un reto más hacia el futuro. Cuadernos de Salud Núm. 1. Población y Salud. Distrito Federal, México: Secretaría de Salud; 1994.

  4. Consejo Nacional de Población. Proyecciones de la población de México 2000-2050. Distrito Federal, México: Consejo Nacional de Población; 2006. Disponible en http://www.conapo.gob.mx/00cifras/5.htm

  5. Instituto Mexicano del Seguro Social. Informe al Ejecutivo Federal y al Congreso de la Unión sobre la Situación Financiera y los Riesgos del Instituto Mexicano del Seguro Social. 2005-2006. Distrito Federal, México: Instituto Mexicano del Seguro Social; 2006.

  6. Instituto Mexicano del Seguro Social. Dirección de Planeación y Finanzas, Coordinación de Administración de Riesgos Institucionales. Informe a la XCI Asamblea General de la Evaluación de Riesgos Contenidos en el Programa de Administración de Riesgos 2002. Distrito Federal, México: Instituto Mexicano del Seguro Social; 2002. Disponible en www.imss.gob.mx/IMSS/IMSS_INF/2002/ejecutivo.htm

  7. Martínez-Salgado H, Villasís MA, et al. Las múltiples facetas de la investigación en salud 4. Distrito Federal, México: Instituto Mexicano del Seguro Social; 2005.

  8. Organización Mundial de la Salud. Clasificación Internacional de Enfermedades. Décima revisión. Ginebra, Suiza: Organización Mundial de la Salud; 1995.

  9. Dixon A, Massialov E, editors. Health care systems in eight countries: trends and challenges. European Observatory on Health Care Systems. London, United Kingdom: The London School of Economics and Political Science; 2002.

  10. Benbassat J, Haklai Z, Glick S, Friedman N. Determinants of hospital utilization: the situation in Israel and selected countries. Isr Med Assoc J 2000; 2(11):833-837.

  11. Lees B. The cost of diabetes and its complications. Soc Sci Med 1992;35:1303-1310.

  12. Kangas T, Aro S, Koivisto VA, Salinto M, Laakso M, Reunanen A. Structure and costs of health care of diabetic patients in Finland. Diabetes Care 1996;19:494-497.

  13. Hart WM, Espinosa C, Rovira J. El coste de la diabetes mellitus conocida en España. Med Clin (Barc) 1997;109:289-293.

  14. American Diabetes Association. Economic costs of diabetes in the U.S. in 2002. Disponible en http://care.diabetesjournals.org/cgi/content/full/26/3/917

  15. Brown JB, Pedula KL, Bakst AW. The progressive cost of complications in type 2 diabetes mellitus. Arch Intern Med 1999;159(16):1873-1880. Disponible en http://archinte.ama-assn.org/cgi/content/abstract/159/16/1873

  16. Kidney Care Partners. The Dialysis Experience. Disponible en: www.kidneycarepartners.org/dialysis/index.html

  17. End-Stage Renal Disease: Scope and Trends. Disponible en www.princeton.edu/cgi-bin/byteserv.prl/~ota/disk2/1985/8531/853104.PDF

  18. Lamping DL, Constantinovici N, Roderick P, Normand C, Henderson L, Harris S, et al. Clinical outcomes, quality of life, and costs in the North Thames Dialysis Study of elderly people on dialysis: a prospective cohort study. Lancet 2000; 356(9241):1543-1550.

  19. Odell TW, Gregory MC. Cost of hypertension treatment. J Gen Intern Med 1995;10(12) 686-688.

  20. Degli-Esposti E, Berto P, Ruffo P, Buda S, Degli-Esposti L, Sturani A, Pandora Study Group. The PANDORA project: results of the cost of illness analysis. J Hum Hypertens 2001;15(5):329-334.

  21. Moore R. Costs. 12th World AIDS Conference. Geneva, Switzerland; 1998.

  22. Emiko M, Russell G. Long-term costs and savings from HAART in resource-scarce countries. School of Public Health, University of California, Berkeley. Disponible en http://big.berkeley.edu/barcelonaslides.ppt#288,2,Motivation

  23. American Cancer Society. What are the key statistics for cervical cancer. Cancer reference information. Disponible en http://www.cancer.org

  24. Robles SC, White F, Peruga A. Trends in cervical cancer mortality in the Americas. Bull Pan Am Health Organ 1996;30(4):290-301.




2020     |     www.medigraphic.com